A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol in the treatment of bronchiectasis

Trial Profile

A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol in the treatment of bronchiectasis

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2016

At a glance

  • Drugs Mannitol (Primary)
  • Indications Bronchiectasis
  • Focus Registrational; Therapeutic Use
  • Sponsors Pharmaxis
  • Most Recent Events

    • 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
    • 09 Sep 2013 Primary endpoint 'Symptom-exacerbation-rate' has not been met.
    • 09 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top